Excessive Warfarin Anticoagulation - Causes and Consequences (EWA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02761941|
Recruitment Status : Unknown
Verified May 2016 by Juhani Airaksinen, University of Turku.
Recruitment status was: Recruiting
First Posted : May 4, 2016
Last Update Posted : May 5, 2016
|Condition or disease|
This is a retrospective study setting. Source data will be collected by reviewing medical records and through computer searches. The basic study population will be identified from laboratory INR test results taken between 2003-2015.
Identifying patients with INR values over 9 will be selected for further analysis, concerning the clinical presentation, patient characteristics, 90 day survival and adverse event rates. The focus is in identifying patient characteristics and factors influencing the risk of high INR value. Also we will analyse the effects of medically reversing the high INR values on stroke and other adverse event rates. The results will be collected manually using an electronic case report form, and analysed statistically using SPSS/SAS statistics tool.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||25000 participants|
|Target Follow-Up Duration:||90 Days|
|Official Title:||Excessive Warfarin Anticoagulation - Causes and Consequences|
|Study Start Date :||May 2016|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
- All cause mortality [ Time Frame: 90 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02761941
|Contact: Tuija Vasankari, RN||+358 2 firstname.lastname@example.org|
|Turku University Hospital||Recruiting|
|Contact: Juhani Airaksinen, prof +35823131005 email@example.com|
|Contact: Tuomas Kiviniemi, MD, PhD +35823130787 firstname.lastname@example.org|
|Principal Investigator: Juhani Airaksinen, Prof|
|Sub-Investigator: Tuomas Kiviniemi, MD, PhD|
|Sub-Investigator: Fausto Biancari, MD, PhD|
|Sub-Investigator: Samuli Jaakkola, MD|
|Sub-Investigator: Ilpo Nuotio, MD, PhD|
|Principal Investigator:||Juhani Airaksinen, Professor||Turku University Hospital|